Skip to main content

Churchill Downs Incorporated Announces Definitive Agreement to Acquire Preakness Intellectual Property Rights

LOUISVILLE, Ky., April 21, 2026 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (the “Company”, “CDI”, “we”) announced today that it has entered into a definitive agreement to acquire the intellectual property, including all trademarks and associated rights, of the Preakness Stakes and Black-Eyed Susan Stakes (the “Preakness IP Rights”) from 1/ST Maryland LLC, an affiliate of 1/ST Racing, for a purchase price of $85 million, subject to customary closing conditions (the “Transaction”). The Preakness IP Rights are subject to an Exclusive License Agreement pursuant to which CDI will license to the State of Maryland the intellectual property rights necessary to conduct the running of the Preakness Stakes and Black-Eyed Susan Stakes in exchange for an annual fee. The Preakness Stakes, first run in 1873, is the second...

Continue reading

Multitude AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Multitude AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements21. Apr 2026 / 15:00 CET/CEST, transmitted by GlobeNewswire.The issuer is solely responsible for the content of this announcement.Multitude AG hereby announces that the following financial reports shall be disclosed:Report type: Quarterly report and quarterly/interim statementDate of disclosure: 21.05.2026Language: English Address: https://www.multitude.com/investors/results-reports-and-publications/2026End of messageGlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.Archive at www.globenewswire.comLanguageEnglishCompanyMultitude AG...

Continue reading

White River Bancshares Co. Reports Net Income of $3.4 million, or $1.38 Per Diluted Share, for the First Quarter of 2026

FAYETTEVILLE, Ark., April 21, 2026 (GLOBE NEWSWIRE) — White River Bancshares Company (OTCQX: WRIV) (the “Company”), the holding company for Signature Bank of Arkansas (the “Bank”), today reported net income of $3.38 million, or $1.38 per diluted share, in the first quarter of 2026, compared to $4.36 million, or $1.78 per diluted share, in the fourth quarter of 2025, and $2.63 million, or $1.07 per diluted share, in the first quarter of 2025. “Our first quarter results reflect strong growth and solid performance across the bank, a direct outcome of the genuine relationships we build with our customers and communities,” said Gary Head, Chief Executive Officer. “Community banking is about earning trust over time through authentic customer service, and that mentality drives everything we do. Our bankers deliver thoughtful solutions...

Continue reading

SunCar Wins Major Bid to Manage Agricultural Bank of China’s Concierge Chauffeur Services

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — SunCar Technology Group Inc. (the “Company” or “SunCar”) (NASDAQ: SDA), a leader in digitalizing auto insurance and services in China, has won the contract to manage all concierge chauffeur services for the Agricultural Bank of China (“AgBank”). AgBank is generally considered the second-largest bank in the world in terms of total assets. AgBank is consolidating its concierge chauffeur services on SunCar’s management platform to improve customer experience and rationalize costs. SunCar’s platform will manage these services for three groups: Private Banking Department, Personal Banking, and the Credit Card Center. The contract has a term of three years and a total estimated value of $50 million for the Company over the length of the contract. The successful bid included...

Continue reading

Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™

Payer access for Emrosi™ expanded from approximately 100 million commercial lives to over 150 million commercial lives as of April 1, 2026 SCOTTSDALE, Ariz., April 21, 2026 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company primarily focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that approximately 85% of all commercial lives in the United States now have access to Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) after contracting with the third major group purchasing organization (GPO). Emrosi™ is for the treatment of inflammatory...

Continue reading

Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced that it plans to release first quarter 2026 financial and operating results prior to market open on Tuesday, May 5, 2026. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/3pztkve5. To listen to the conference call on your telephone, participants may register for the call here. While it is not required, it is recommended you join 10 minutes prior...

Continue reading

HomeTrust Bank Celebrates Opening Day at HomeTrust Park with the Asheville Tourists

ASHEVILLE, N.C., April 21, 2026 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NYSE: HTB), the holding company of HomeTrust Bank (“HomeTrust” or the “Bank”), today celebrates the opening of the Asheville Tourists’ 2026 season at the newly renamed HomeTrust Park. The partnership, announced last week, unites two institutions deeply rooted in the Asheville community: the Asheville Tourists, one of Minor League Baseball’s most storied franchises, and HomeTrust Bank, a financial institution with over 100 years of service in Western North Carolina. Both the Tourists and HomeTrust share a longstanding commitment to the people and future of Asheville. “HomeTrust Bank and the Asheville Tourists share more than a name on a ballpark: we share a home and a century-long commitment to this community. As the only bank headquartered in Asheville,...

Continue reading

Euronet to Host Investor Day on May 20, 2026

LEAWOOD, Kan., April 21, 2026 (GLOBE NEWSWIRE) — Euronet (NASDAQ: EEFT), a global leader in payments processing and cross-border transactions, announced it will host an Investor Day on Wednesday, May 20, 2026, beginning at 10:00 a.m. Eastern Time. The Investor Day will be webcast on the Euronet Investor Relations website. Participants can register for the webcast at the following link:Euronet 2026 Investor DayDuring the event, Euronet’s management team will provide an in-depth presentation of the Company’s strategic vision, growth drivers, business segments, competitive positioning, and financial outlook. A replay of the webcast will be available following the live event and archived on the Euronet Investor Relations website. About Euronet A global leader in payments processing and cross-border transactions, Euronet moves money...

Continue reading

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech,” please visit: https://ibn.fm/URkQF Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector historically defined by long timelines and uncertain outcomes. As drug candidates advance closer to commercialization, scientific...

Continue reading

Cycurion, Inc. Provides Update on Revised Memorandum of Understanding to Acquire Kustom Entertainment’s Legacy Video Solutions Segment

Both Parties Agree to Accelerate Closing Target Date to Beginning of June 2026 MCLEAN, Va., April 21, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading provider of AI-driven cybersecurity, IT security solutions, and managed services, today provided an update on the revised non-binding Memorandum of Understanding (“MOU”) with Kustom Entertainment, Inc. (NASDAQ: KUST) (“Kustom”) for the acquisition of Kustom’s legacy video solutions segment (the “Business”). The transaction is expected to contribute approximately $5.1 million in annual revenue and an estimated $8.0 million backlog comprised of established contracts and recurring subscription revenue. These figures are based on the pro forma financials jointly prepared by both parties and are consistent with the segment’s historical performance. Both...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.